Welcome to the InfoSci Platform
Biopharma Innovation Models for Gulf Region in the Era of Globalisation

Biopharma Innovation Models for Gulf Region in the Era of Globalisation

Rakhi Rashmi
Copyright: © 2019 |Pages: 31
ISBN13: 9781522589037|ISBN10: 1522589031|EISBN13: 9781522589044
DOI: 10.4018/978-1-5225-8903-7.ch086
Cite Chapter Cite Chapter

MLA

Rashmi, Rakhi. "Biopharma Innovation Models for Gulf Region in the Era of Globalisation." Biotechnology: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, IGI Global, 2019, pp. 2123-2153. https://doi.org/10.4018/978-1-5225-8903-7.ch086

APA

Rashmi, R. (2019). Biopharma Innovation Models for Gulf Region in the Era of Globalisation. In I. Management Association (Ed.), Biotechnology: Concepts, Methodologies, Tools, and Applications (pp. 2123-2153). IGI Global. https://doi.org/10.4018/978-1-5225-8903-7.ch086

Chicago

Rashmi, Rakhi. "Biopharma Innovation Models for Gulf Region in the Era of Globalisation." In Biotechnology: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, 2123-2153. Hershey, PA: IGI Global, 2019. https://doi.org/10.4018/978-1-5225-8903-7.ch086

Export Reference

Mendeley
Favorite

Abstract

Biopharmaceutical is the most upcoming segment of the pharmaceutical industry as the use of biotechnology has the potential to provide cures for the most life threatening and difficult ailments. At the same time for biopharma innovation, factors such as increasing costs, high continuous funding, and risk funding are of increasing concern for the emerging economies. This chapter measures the strength of biopharma innovation indicators in Gulf Cooperation Council (GCC) and explores the potential biopharma innovation models for gulf countries.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.